BUPROPION vs SOLRIAMFETOL: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
BUPROPION vs SOLRIAMFETOL: Safety Overview
| Metric | BUPROPION | SOLRIAMFETOL |
|---|---|---|
| Total FAERS Reports | 35,634 | 2,135 |
| Deaths Reported | 8,577 | 9 |
| Death Rate | 24.1% | 0.4% |
| Hospitalizations | 10,246 | 75 |
| Average Patient Age | 44.6 yrs | 43.2 yrs |
| % Female Patients | 70.7% | 71.4% |
| FDA Approval Date | Apr 12, 2017 | Jun 17, 2019 |
| Manufacturer | NuCare Pharmaceuticals, Inc. | Axsome Therapeutics, Inc. |
| Route | ORAL | ORAL |
| Marketing Status | Discontinued | Prescription |